International Edition
Latest News
Technology

Structure-Guided mRNA Vaccine Fully Protects Against Nipah and Hendra Viruses

Structure-guided mRNA vaccine protects against henipaviruses Researchers developed a structure-guided mRNA vaccine strategy targeting henipaviruses, achieving complete survival in animal challenge models. The findings, published in Nature, address high case fatality rates associated with zoonotic paramyxoviruses like Nipah…

Structure-guided mRNA vaccine protects against henipaviruses

Researchers developed a structure-guided mRNA vaccine strategy targeting henipaviruses, achieving complete survival in animal challenge models. The findings, published in Nature, address high case fatality rates associated with zoonotic paramyxoviruses like Nipah and Hendra viruses, which currently lack licensed human vaccines.

Scientists engineered Nipah virus F glycoproteins stabilized in the prefusion conformation to identify a lead candidate designated F-205, Nature reported. This candidate stops syncytium formation and triggers high prefusion-specific antibody titers. Co-delivering F-205 and G antigens using mRNA-lipid nanoparticles prompts strong neutralizing and cellular immune responses.

Golden hamster challenge models showed that the vaccine delivers complete survival against lethal exposures of Nipah virus M, Nipah virus B, and Hendra virus. Researchers found viral RNA undetectable in the lungs, spleens, and brains of subjects following Nipah challenges. Viral burdens dropped significantly after Hendra virus challenges.

The team also introduced surrogate assays to evaluate F conformation and fusion activity under standard biosafety conditions. These assays allow researchers to optimize antigens without handling live viruses, according to the study. The approach establishes a generalizable framework for designing mRNA vaccines that target class I fusion viruses.

Frequently asked questions about the mRNA vaccine

Which viruses does the new mRNA vaccine protect against?

The vaccine protects against Nipah virus and Hendra virus. Both pathogens belong to the henipavirus genus of zoonotic paramyxoviruses.

What animal models were used to test the vaccine efficacy?

Researchers tested the vaccine using stringent golden hamster challenge models. The subjects received lethal challenges of Nipah virus M, Nipah virus B, and Hendra virus.

How does the vaccine candidate prevent live virus risks during testing?

Scientists use surrogate assays to assess F conformation and fusion activity under standard biosafety conditions. This allows iterative antigen optimization without requiring live-virus handling.

About the author: Technology Desk

Technology Desk at Archynewsy.